&gt

15 trials

Sponsors

Japanese Foundation for Multidisciplinary Treatment of Cancer, Kanagawa Cancer Center, Fukuoka Tumor Research(FUTURE), Chigasaki Municipal Hospital, Kobe University Graduate School of Medicine

Conditions

Advanced or recurrent gastric cancerHealthy 3-4 year old infants with no previous IV therapy within the past yearHealthy adultsHealthy subjectsHypertension, hyperlipemia, gout, glycohemia, diabetes, abnormal glucose tolerance, a fatty liver, obstipation, healthyMelanomaPancreatic ductal adenocarcinomaadvanced colorectal cancer

Phase 2

A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy

Active, not recruitingJPRN-C000000099

Japanese Foundation for Multidisciplinary Treatment of CancerAdvanced or recurrent gastric cancer

Start: 2003-08-01Target: 90Updated: 2026-06-29

Phase II study of S-1 for elderly patients with unresectable pancreatic cancer

Active, not recruitingJPRN-UMIN000006369

Chigasaki Municipal Hospitalpancreatic cancer

Start: 2007-11-01Target: 21Updated: 2026-06-29

The phase 2 study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with biological borderline resectable pancreatic cancer.

RecruitingJPRN-UMIN000030717

Department of gastrointestinal Surgery, Hiroshima University HospitalPancreatic ductal adenocarcinoma

Start: 2019-03-04Target: 50Updated: 2026-06-29

Phase 3

A randomized, double-blind, placebo-controlled, phase III study comparing the combination of PDR001, dabrafenib and trametinib versus placebo, dabrafenib and trametinib in previously untreated patients with unresectable or metastatic BRAF V600 mutant melanoma

Active, not recruitingNL-OMON54792

NovartisMelanoma

Start: 2017-12-13Target: 8Updated: 2025-09-01

Phase 4

Catheter ablation with power titration according to contact force in patients undergoing pulmonary vein isolation

Active, not recruitingKCT0002517

Asan Medical Center

Start: 2017-11-10Target: 100Updated: 2019-03-11

Unknown Phase

A phase I/II study of Cetuximab combined with irinotecan and S-1 as first line therapy in metastatic colorectal cancer patients with KRAS wild type

Active, not recruitingJPRN-UMIN000004403

Kanagawa Cancer Centeradvanced colorectal cancer

Start: 2010-11-01Target: 40Updated: 2026-06-29

A phase II study of Panitumumab combined with Irinotecan and S-1 as second line therapy in metastatic colorectal cancer patients with KRAS wild type

RecruitingJPRN-UMIN000004697

Kanagawa Cancer Centeradvanced colorectal cancer

Start: 2010-12-01Target: 30Updated: 2026-06-29

A phase I/II study of combination therapy with S-1/ CPT-11 plus Panitumumab as second line therapy in metastatic colorectal cancer patients with KRAS wild type

Active, not recruitingJPRN-UMIN000005218

Fukuoka Tumor Research(FUTURE)metastatic colorectal cancer

Start: 2011-03-01Target: 35Updated: 2026-06-29

Study on lifestyle-related disease improvement effect by the kombu intake

Active, not recruitingJPRN-UMIN000009799

Kobe University Graduate School of MedicineHypertension, hyperlipemia, gout, glycohemia, diabetes, abnormal glucose tolerance, a fatty liver, obstipation, healthy

Start: 2013-01-31Target: 540Updated: 2026-06-29

Effects of MSG on lingual taste receptors gene expressions in healthy subjects.

JPRN-UMIN000018824

Tokushima Universityhealthy adults

Start: 2015-10-01Target: 30Updated: 2026-06-29

Investigation of the effect of minoxidil for congenital hypotrichosis and woolly hair

Active, not recruitingJPRN-UMIN000019724

Nagoya University Graduate School of Medicine Dermatologycongenital hypotrichosis and woolly hair

Start: 2016-08-01Target: 40Updated: 2026-06-29

The randomized double blind cross-over test of the effect of citric acid intake on physical fatigue after exercise

JPRN-UMIN000021285

Wakayama Medical UniversityHealthy subjects

Start: 2016-03-03Target: 20Updated: 2026-06-29

Study on effects of a cereal derived processed product on postprandial energy metabolism.

Active, not recruitingJPRN-UMIN000023781

Kao CorporationHealthy adults

Start: 2016-09-05Target: 50Updated: 2026-06-29

Solute removal of hybrid online hemodiafiltration compared to pre-dilution online hemodiafiltration

Active, not recruitingJPRN-UMIN000038028

Division of Clinical Engineering, Toujinkai Hospitalchronic kidney disease/dialysis patient

Start: 2019-02-20Target: 10Updated: 2026-06-29

A Study of Behavioral Characteristics of Children with Simulated Intravenous Infusion Fixation

RecruitingJPRN-UMIN000052833

Tokyo Healthcare UniversityHealthy 3-4 year old infants with no previous IV therapy within the past year

Start: 2023-06-25Target: 20Updated: 2026-06-29